跳至主要内容
临床试验/NCT04706065
NCT04706065Unknown不适用

Genetic Polymorphisms of Serine Hydroxylmethyl Transferase 1 (SHMT1) in Patients With Parkinson's Disease

Assiut University1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年1月31日最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
polymorphism of SHMT1gene

研究概览

简要总结

Parkinson Disease (PD) is the most common movement disorder and represents the second most common degenerative disease of the central nervous system . SHMT has been shown to be associated with various diseases.

详细描述

This case -control observational prospective study will conducted on 40 patients with PD.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients age ≥ 50 years.
  • Patients with PD diagnosed according to the United Kingdom Parkinson's Disease Society Brain Bank (UK PDS Brain Bank diagnostic criteria)

排除标准

  • Patients with parkinsonian plus syndrome
  • Patients with secondary parkinsonism
  • Patients with other chronic comorbidities (renal, hepatic, and endocrinal disturbances and chronic chest disease.)
  • Past and /or present history of epilepsy.
  • Patients with disturbed conscious level.

结局指标

主要结局

polymorphism of SHMT1gene

时间窗: one year

次要结局

  • the role of SHMT1plymorphism in pathogenesis PD(one year)
  • Study the relationship of Shmt1 polymorphism to the severity of Parkinson disease(One year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Effat AETony, MD

professor of internal medicine

Assiut University

研究点 (1)

Loading locations...

相似试验